Targacept CEO deBethizy resigns from the N.C. biotech
Targacept (NASDAQ:TRGT), already in the midst of a corporate restructuring, must now also search for a new CEO. Don deBethizy is resigning from his positions as CEO and chairman of the drug development company. In a statement, deBethizy said he “decided to step down for personal considerations.” But the move follows some setbacks for the […]